DOI QR코드

DOI QR Code

The role of 18F-fluorodeoxyglucose positron emission tomography in the assessment of disease activity of adult-onset Still's disease

  • An, Young-Sil (Department of Nuclear Medicine and Molecular Imaging, Ajou University School of Medicine) ;
  • Suh, Chang-Hee (Department of Rheumatology, Ajou University School of Medicine) ;
  • Jung, Ju-Yang (Department of Rheumatology, Ajou University School of Medicine) ;
  • Cho, Hundo (Department of Rheumatology, Ajou University School of Medicine) ;
  • Kim, Hyoun-Ah (Department of Rheumatology, Ajou University School of Medicine)
  • Received : 2015.09.26
  • Accepted : 2015.11.23
  • Published : 2017.11.01

Abstract

Background/Aims: $^{18}F-fluorodeoxyglucose$ positron emission tomography/computed tomography ($^{18}F-FDG$ PET/CT) has been suggested as a reliable imaging technique for monitoring of disease activity in patients with adult-onset Still's disease (AOSD). Therefore, we investigated the clinical significance of $^{18}F-FDG$ PET/CT in Korean AOSD patients. Methods: Thirteen AOSD patients were included in the study. The PET/CT images were evaluated with visual and semiquantitative method using standardized uptake values (SUVs). Results: The presence of increased $^{18}F-FDG$ uptake was noted in 90% of clinically active AOSD patients. $^{18}F-FDG$ uptake was located in the lymph node, spleen, and bone marrow. Visual grade and SUV intensity of lymph node was significantly correlated with the systemic score of AOSD. Visual grade of spleen was significantly correlated with the systemic score, erythrocyte sedimentation rate (ESR), and ferritin. Additionally, visual grade and SUV intensity of bone marrow was significantly correlated with the systemic score, ESR, leukocyte, and neutrophil. Conclusions: Visual grade and SUV intensity of lymph node, spleen, and bone marrow on $^{18}F-FDG$ PET/CT scan showed significant correlations with known disease activity markers. The data suggest that $^{18}F-FDG$ PET/CT scan may be a useful imaging technique for evaluation of disease activity in AOSD patients.

Keywords

References

  1. Bywaters EG. Still's disease in the adult. Ann Rheum Dis 1971;30:121-133. https://doi.org/10.1136/ard.30.2.121
  2. Bujak JS, Aptekar RG, Decker JL, Wolff SM. Juvenile rheumatoid arthritis in the adult presenting as fever of unknown origin. Trans Assoc Am Physicians 1972;85:181-191.
  3. Pouchot J, Sampalis JS, Beaudet F, et al. Adult Still's disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore) 1991;70:118-136. https://doi.org/10.1097/00005792-199103000-00004
  4. Ohta A, Yamaguchi M, Kaneoka H, Nagayoshi T, Hiida M. Adult Still's disease: review of 228 cases from the literature. J Rheumatol 1987;14:1139-1146.
  5. Ambrosini V, Zompatori M, Fasano L, et al. (18)F-FDG PET/CT for the assessment of disease extension and activity in patients with sarcoidosis: results of a preliminary prospective study. Clin Nucl Med 2013;38:e171-e177. https://doi.org/10.1097/RLU.0b013e31827a27df
  6. Cheng Y, Lv N, Wang Z, Chen B, Dang A. 18-FDG-PET in assessing disease activity in Takayasu arteritis: a meta-analysis. Clin Exp Rheumatol 2013;31(1 Suppl 75):S22-S27.
  7. Cohen C, Mekinian A, Uzunhan Y, et al. 18F-fluorodeoxyglucose positron emission tomography/computer tomography as an objective tool for assessing disease activity in Sjogren's syndrome. Autoimmun Rev 2013;12:1109-1114. https://doi.org/10.1016/j.autrev.2013.06.012
  8. Lee KH, Cho A, Choi YJ, et al. The role of (18) F-fluorodeoxyglucose-positron emission tomography in the assessment of disease activity in patients with Takayasu arteritis. Arthritis Rheum 2012;64:866-875. https://doi.org/10.1002/art.33413
  9. Choe JY, Chung DS, Park SH, Kwon HH, Kim SK. Clinical significance of 18F-fluoro-dexoxyglucose positron emission tomography in patients with adult-onset Still's disease: report of two cases and review of literatures. Rheumatol Int 2010;30:1673-1676. https://doi.org/10.1007/s00296-009-1137-7
  10. Funauchi M, Ikoma S, Kishimoto K, et al. A case of adult onset Still's disease showing marked accumulation in the liver and spleen, on positron emission tomography-CT images. Rheumatol Int 2008;28:1061-1064. https://doi.org/10.1007/s00296-008-0562-3
  11. Cunha ML, Wagner J, Osawa A, Scheinberg M. The effect of tocilizumab on the uptake of 18FDG-PET imaging in patients with adult-onset Still's disease. Rheumatology (Oxford) 2010;49:1014-1016. https://doi.org/10.1093/rheumatology/kep441
  12. de Graaff LC, ten Broek MR, Schweitzer DH. Is Still's disease still one disease? A case of Adult-onset Still's disease showing accumulation in the carotids and the large vessels of the legs on positron emission tomography: CT images. Rheumatol Int 2012;32:2487-2490. https://doi.org/10.1007/s00296-011-1991-y
  13. Cai L, Chen Y, Huang Z. Elevated FDG activity in lymph nodes as well as the spleen and liver in a patient with adult-onset still disease. Clin Nucl Med 2012;37:1009-1010. https://doi.org/10.1097/RLU.0b013e31826386d2
  14. Yamashita H, Kubota K, Takahashi Y, et al. Clinical value of 18F-fluoro-dexoxyglucose positron emission tomography/computed tomography in patients with adult-onset Still's disease: a seven-case series and review of the literature. Mod Rheumatol 2014;24:645-650. https://doi.org/10.3109/14397595.2013.850998
  15. Dong MJ, Wang CQ, Zhao K, et al. 18F-FDG PET/CT in patients with adult-onset Still's disease. Clin Rheumatol 2015;34:2047-2056. https://doi.org/10.1007/s10067-015-2901-6
  16. Yamaguchi M, Ohta A, Tsunematsu T, et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol 1992;19:424-430.
  17. Paes FM, Kalkanis DG, Sideras PA, Serafini AN. FDG PET/CT of extranodal involvement in non-Hodgkin lymphoma and Hodgkin disease. Radiographics 2010;30:269-291. https://doi.org/10.1148/rg.301095088
  18. Fuchs M, Briel M, Daikeler T, et al. The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis. Eur J Nucl Med Mol Imaging 2012;39:344-353. https://doi.org/10.1007/s00259-011-1967-x
  19. Mostard RL, van Kroonenburgh MJ, Drent M. The role of the PET scan in the management of sarcoidosis. Curr Opin Pulm Med 2013;19:538-544. https://doi.org/10.1097/MCP.0b013e328363ed0d
  20. Neurath MF, Vehling D, Schunk K, et al. Noninvasive assessment of Crohn's disease activity: a comparison of 18F-fluorodeoxyglucose positron emission tomography, hydromagnetic resonance imaging, and granulocyte scintigraphy with labeled antibodies. Am J Gastroenterol 2002;97:1978-1985. https://doi.org/10.1111/j.1572-0241.2002.05836.x
  21. Buysschaert I, Vanderschueren S, Blockmans D, Mortelmans L, Knockaert D. Contribution of (18)fluoro-deoxyglucose positron emission tomography to the work-up of patients with fever of unknown origin. Eur J Intern Med 2004;15:151-156. https://doi.org/10.1016/j.ejim.2004.01.018
  22. Blockmans D, Knockaert D, Maes A, et al. Clinical value of [(18)F]fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin. Clin Infect Dis 2001;32:191-196. https://doi.org/10.1086/318480
  23. Bleeker-Rovers CP, Corstens FH, Van Der Meer JW, Oyen WJ. Fever of unknown origin: prospective comparison of diagnostic value of (18)F-FDG PET and (111)In-granulocyte scintigraphy. Eur J Nucl Med Mol Imaging 2004;31:1342-1343 https://doi.org/10.1007/s00259-004-1634-6
  24. Ahn BC, Lee SW, Lee J. Intense accumulation of F-18 FDG in colonic wall in adult onset still disease with pseudomembranous colitis. Clin Nucl Med 2008;33:806-808. https://doi.org/10.1097/RLU.0b013e318187eec4
  25. Vranken E, Versijpt J, Winne L, Veys EM, Hamphrey H. Adult-onset Still disease: evaluation with serial f-18 fluorodeoxyglucose positron emission tomography. Clin Nucl Med 2005;30:740-741. https://doi.org/10.1097/01.rlu.0000182267.90379.dd
  26. Liu Y. Clinical significance of diffusely increased splenic uptake on FDG-PET. Nucl Med Commun 2009;30:763-769. https://doi.org/10.1097/MNM.0b013e32832fa254
  27. Nunez R, Rini JN, Tronco GG, Tomas MB, Nichols K, Palestro CJ. Correlation of hematologic parameters with bone marrow and spleen uptake in FDG PET. Rev Esp Med Nucl 2005;24:107-112. https://doi.org/10.1157/13071686

Cited by

  1. Utility and drawbacks of [18]F-fluorodeoxyglucose positron emission tomography in the evaluation of adult-onset Still’s disease vol.32, pp.6, 2017, https://doi.org/10.3904/kjim.2017.342
  2. 18 F-Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography With Magnetic Resonance for Diagnosing Adult-Onset Still's Disease vol.7, pp.None, 2017, https://doi.org/10.3389/fmed.2020.544412
  3. Utility of Magnetic Resonance Imaging and Positron Emission Tomography in Rheumatic Diseases vol.27, pp.3, 2017, https://doi.org/10.4078/jrd.2020.27.3.136
  4. FDG PET/CT used in identifying adult-onset Still’s disease in connective tissue diseases vol.39, pp.9, 2020, https://doi.org/10.1007/s10067-020-05041-3
  5. 18F-FDG PET/CT Associates With Disease Activity and Clinical Recurrence of AOSD Patients vol.8, pp.None, 2017, https://doi.org/10.3389/fmed.2021.668323
  6. Characteristics and Clinical Value of 18F-FDG PET/CT in the Management of Adult-Onset Still’s Disease: 35 Cases vol.10, pp.11, 2017, https://doi.org/10.3390/jcm10112489